Dina Kouveliotes' Healthcare News & Commentary

Dina Kouveliotes

Wednesday, April 11, 2012

2012 Cardiometabolic Health Congress: Late-Breaking Clinical Trials & FDA Update – What You Need to Know

Late-Breaking Clinical Trials & FDA Update – What You Need to Know
Posted by Unknown at 11:37 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Blog Archive

  • ►  2015 (3)
    • ►  July (1)
    • ►  March (2)
  • ►  2013 (18)
    • ►  December (1)
    • ►  March (3)
    • ►  February (14)
  • ▼  2012 (9)
    • ►  August (1)
    • ▼  April (8)
      • Resistant Hypertension: An Update of Devices on th...
      • Exenatide Approved in Combination with Basal Insul...
      • What is the Most Important Unanswered Question in ...
      • Do ARBs Cause Cancer? - Keith Ferdinand, MD
      • 2012 Cardiometabolic Health Congress: Late-Breakin...
      • CMHC and National Kidney Month – Important Announc...
      • Cardiometabolic Health Congress - 8 Symposia and 2...
      • Invite on Behalf of Drs. Bakris, Ballantyne, Eckel...

CMHC Blogger

Unknown
View my complete profile
Simple theme. Powered by Blogger.